Therapeutic Antibodies
| Focus: | Therapeutic antibodies |
|---|---|
| Type: | database (supplied by e-mail as setup.exe file) |
| No. of deals: | 149 |
| No. of companies: | 150 |
| Years covered: | 1996 – 2011 |
| Price: | € 700 ex VAT (if applicable) |
| System requirements: | Windows 2000/Windows XP/Windows Vista/7 |
| Publisher: | PharmaPlus Consultancy B.V. |
Are you about to enter deal negotiations for your antibody therapeutic?
Use PharmaDeal Financials Therapeutic Antibodies to benchmark your next antibody deal
PharmaDeal Financials Therapeutic Antibodies
- Deal specifics on almost 150 therapeutic antibody deals
- Deal making trends since 1996
- Big pharma licensees including Abbott, Boehringer Ingelheim and Johnson & Johnson
- 52% oncology-related deals
- 20% autoimmune-related deals
- 54% early stage deals
- Phase II regulatory milestones from USD 2 to USD 21.5 million
- Royalties up to 39%
Each deal entry is categorized and searchable by licensor, licensee, indication, compound details, compound name, development stage (research-filed), geographical territory, potential deal size, upfront, total milestones-regulatory milestones-sales milestones payments, profit sharing, royalties on sales, research funding, equity and by year of deal establishment or any combination thereof.
Antibody keywords
Antibody drug conjugates, antibody fragments (polyclonal), antibody tumor targeting, bispecific antibodies, BiTe antibodies, domain antibodies, linked antibodies, monoclonal antibodies, nanobodies, radiolabeled antobodies, targeted antibody payload, tumor activated prodrugs
Disease areas included in database
Autoimmune disorders, blood & forming organs, cardiovascular disorders, central nervous system disorders, dermatological disorders, eye disorders, gastrointestinal disorders, immunological disorders, inflammatory disorders, infectious diseases, inflammatory disorders, metabolic disorders, musculoskeletal disorders, oncology, respiratory disorders, transplantation, women’s health
Companies included in database
4-Antibody, Abbott Laboratories, Ablynx, AC Immune, Affitech, Agensys, Alexion Pharmaceuticals, Alopexx Pharmaceuticals, Amgen (Abgenix), Antisoma, Argos Therapeutics, Astellas Pharma (UroGenesys), AstraZeneca (Cambridge Antibody Technology, MedImmune), Aveo Pharmaceuticals, Bayer (Schering AG), Biogen Idec (Biogen, Idec Pharmaceuticals), Biohybrid, BioInvent International, Biotest, BioTie Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb (Medarex), BTG (Protherics), Celldex Therapeutics (Curagen) Celtic Pharma (Xenova), Cubist Pharmaceuticals, Cytokine PharmaSciences (Cytokine Networks), Daiichi Sankyo Co. (Sankyo), Danisco (Genencor), Dompé Farmaceutici, Dyax Corporation, Eli Lilly & Company (Applied Molecular Evolution/Ixsys, Imclone Systems), Emergent Biosolutions, Eusa Pharma, Exelixis, f-star, Facet Biotech Corporation (Protein Design Labs/Eos Biotechnology), Fernz Corporation (Pharma Pacific), Galaxy Biotech, Genaera Corporation (Magainin Pharmaceuticals), Genmab, GlaxoSmithKline (Corixa, Coulter Pharmaceuticals, Domantis, SmithKline Beecham), Glenmark Pharmaceuticals, Glenveigh Medical (Glenveigh Pharmaceuticals), Human Genome Sciences, iCo Therapeutics, Immune Pharmaceuticals, Immuno-Biological Laboratories, ImmunoGen, Immunomedics, Immutep, Innate Pharma, Innogene Kalbiotech, Intercell, Ista Pharmaceuticals, Japan Tobacco, Johnson & Johnson (Centocor), Kyowa Hakko Kirin Co. (Kyowa Hakko), Lexicon Pharmaceuticals (Lexicon Genetics), LFB Biotechnologies, Lpath, Lundbeck, MacroGenics, Merck & Co (Schering-Plough/Organon), Merck Serono (Merck KGaA, Serono), Merrimack Pharmaceuticals, Merus Biopharmaceuticals, Micromet, MorphoSys, Neurimmune Therapeutics, Novartis (Chiron), Novimmune, Novo Nordisk, Nycomed, Oncomed Pharmaceuticals, Oncoscience, Oxford BioMedica, Oxford Biotherapeutics, Paladin Labs (Virexx Medical Corporation/Altarex Corporation), PanGenetics, Peregrine Pharmaceuticals (Techniclone), Pfizer (Pharmacia Corporation, G.P. Searle, Wyeth), Pierre Fabre, Procter & Gamble, ProStrakan Group, Purdue Pharma, Regeneron Pharmaceuticals, Roche (Arius Research, Genentech), Sanofi (Genzyme Corporation (Ilex Oncology), Sanofi-Aventis, Sanofi-Pasteur), Scil Technology (Scil Biomedicals), Seattle Genetics, Seikagaku Corporation, Senju Pharmaceuticals, Servier, Symphogen, Taisho Pharmaceutical Co., Takeda Pharmaceutical Company (Millennium Pharmaceuticals/LeukoSite), TenX Biopharma, Thallion Pharmaceuticals, Theraclone Sciences, ThromboGenics, ToleRx, Tracon Pharmaceuticals, Trellis Bioscience, UCB Pharma (Celltech Group), Vernalis (British Biotech), Vivalis, Xencor, Xoma, XTL Biopharmaceuticals, YM Biosciences, Zenyaku Kogyo, Zymeworks, ZymoGenetics
